Imdur is a long-acting nitrate medicine used to help prevent angina (chest pain) in people with coronary artery disease. Its active ingredient, isosorbide mononitrate, relaxes and widens blood vessels, reducing the heart’s workload and improving blood flow. Imdur is taken regularly to decrease the frequency of angina episodes; it does not treat sudden chest pain and is not a rescue medication. Available mainly as extended-release tablets, it is usually dosed once daily with careful titration to balance benefits and side effects. Work with a licensed clinician to ensure appropriate dosing, monitoring, and safety—especially if you take other heart or blood pressure medicines.
Imdur is prescribed to prevent angina pectoris in adults with coronary artery disease. By releasing nitric oxide in the smooth muscle of blood vessel walls, it causes vasodilation—especially venous dilation—reducing preload and myocardial oxygen demand. The result is fewer episodes of chest pain during physical exertion or emotional stress. Imdur is formulated for prevention and maintenance, not for immediate relief; patients should always keep a fast-acting nitrate or other clinician-recommended rescue therapy on hand for acute chest pain and seek emergency care for chest pain that does not promptly resolve.
Clinicians may combine Imdur with other anti-anginal therapies, such as beta blockers or calcium channel blockers, when needed. Because tolerance to nitrates can develop, dosing schedules are designed to include a daily nitrate-free interval. Discuss any exercise changes, smoking cessation efforts, and diet strategies with your care team, as lifestyle modifications work synergistically with Imdur to improve angina control and overall cardiovascular health.
Only your clinician can determine the right dose for you. A common starting dose of extended-release Imdur in adults is 30–60 mg once daily, usually in the morning. Depending on response and tolerability, the dose may be gradually increased, often to 60–120 mg once daily; some patients may require up to 240 mg once daily. Swallow extended-release tablets whole; do not crush, split, or chew them, as this can rapidly release the drug and increase side effects.
Take Imdur consistently at the same time each day. Follow the specific schedule your clinician provides to preserve a nitrate-free interval, which helps reduce tolerance. If headaches occur early in therapy—common with nitrates—speak with your clinician about supportive measures rather than stopping the medication on your own. Never change your dose or dosing schedule without medical guidance.
Imdur can cause dizziness, lightheadedness, or fainting, especially when starting therapy or increasing the dose. Standing up slowly, staying hydrated, and avoiding abrupt position changes can reduce these effects. Use caution when driving or operating machinery until you know how you respond. Alcohol can intensify blood pressure–lowering effects and should be limited or avoided.
Tell your clinician about all medical conditions, including low blood pressure, volume depletion, severe anemia, heart failure, hypertrophic cardiomyopathy, a recent heart attack, or a history of migraines. Nitrates can aggravate headaches initially; these typically lessen over time. Report persistent or severe headaches, unusual fatigue, rapid heartbeat, or new/worsening chest pain promptly.
If you are pregnant, planning pregnancy, or breastfeeding, discuss risks and benefits. Human data are limited; your clinician will consider your specific cardiovascular risk profile. Older adults may be more sensitive to hypotensive effects and require careful monitoring. Keep all follow-up appointments to track blood pressure, angina frequency, and overall response.
Do not use Imdur if you are allergic to isosorbide mononitrate, isosorbide dinitrate, nitroglycerin, or any component of the formulation. Imdur is contraindicated with phosphodiesterase-5 (PDE-5) inhibitors such as sildenafil, tadalafil, or vardenafil, and with the soluble guanylate cyclase stimulator riociguat; combining these can cause life-threatening hypotension. Avoid use in patients with marked hypotension, acute circulatory failure, or shock.
Severe anemia is a relative contraindication, and nitrates may be inappropriate in patients with significantly elevated intracranial pressure. Your clinician will evaluate your cardiovascular status, blood pressure, and concomitant therapies before prescribing Imdur to ensure it is appropriate and safe.
Common side effects include headache, flushing, dizziness, lightheadedness (especially when standing), nausea, and fatigue. These often improve as your body adjusts. Headache is dose-related and a recognized pharmacologic effect of nitrates; talk to your clinician about strategies to manage it without compromising anti-anginal benefits.
Less common effects include low blood pressure, fainting, reflex tachycardia, palpitations, and rash. Seek urgent medical attention if you experience severe or persistent hypotension, syncope, chest pain that does not resolve with rescue medication, shortness of breath, cyanosis, or signs of an allergic reaction (hives, swelling, difficulty breathing). Rarely, high doses or interactions may contribute to methemoglobinemia, presenting with bluish discoloration of skin or lips, fatigue, and shortness of breath—this requires immediate care.
Avoid combining Imdur with PDE-5 inhibitors such as sildenafil (Viagra, Revatio), tadalafil (Cialis, Adcirca), or vardenafil (Levitra, Staxyn), and with riociguat (Adempas). These combinations can precipitate profound, potentially fatal hypotension. If you use a PDE-5 inhibitor for erectile dysfunction or pulmonary hypertension, inform your clinician before starting Imdur. Do not take PDE-5 inhibitors while on nitrates.
Other antihypertensives (beta blockers, calcium channel blockers, alpha blockers, ACE inhibitors, ARBs), diuretics, and alcohol can enhance blood pressure–lowering effects and may increase dizziness or fainting. Your clinician may adjust doses and monitor closely. While some combinations are intentional for angina control, they require supervision.
Be sure to list all prescription and nonprescription drugs, including migraine therapies, over-the-counter cold remedies, herbal supplements, and recreational substances. Do not start or stop medications without professional guidance, as changes can affect angina stability and blood pressure.
If you miss a dose of Imdur, take it as soon as you remember unless it is close to the time for your next dose. If it is nearly time for the next dose, skip the missed dose and resume your regular schedule. Do not take two doses at once to make up for a missed tablet. If you frequently forget doses, consider using reminders or a pill organizer and talk with your clinician about adherence strategies that preserve the nitrate-free interval.
Symptoms of Imdur overdose can include severe headache, flushing, nausea, vomiting, marked hypotension, fainting, rapid heartbeat, shortness of breath, and in rare cases signs of methemoglobinemia (bluish skin or lips, confusion, fatigue). Overdose is a medical emergency. Call emergency services immediately. While awaiting help, lie down and elevate your legs to promote blood flow to the brain if you feel faint. Do not take additional doses, food, or alcohol. Bring the medication container to the emergency department so clinicians can verify the drug and dose.
Store Imdur at room temperature, away from excessive heat, moisture, and light. Keep tablets in their original, tightly closed container, and do not store in a bathroom where humidity is high. As with all medications, keep out of reach of children and pets. Do not use tablets past the expiration date, and dispose of unused or expired medication properly—ask your pharmacist about take-back programs or FDA-recommended disposal methods.
In the United States, Imdur (isosorbide mononitrate) is a prescription-only medication. By law, pharmacies and hospitals cannot dispense Imdur without a valid prescription from a licensed clinician. Claims that you can buy Imdur without prescription—online or locally—should be treated with skepticism, as they may involve illegal or unsafe sources, counterfeit products, or medications that have not been stored or handled properly.
For safe, lawful access, schedule an appointment with your primary care clinician, cardiologist, or a reputable telehealth service. During the visit, your clinician will confirm your diagnosis, review your medications for interactions (including PDE-5 inhibitors and riociguat), and determine the right dosage and monitoring plan. Use licensed U.S. pharmacies—community or mail-order—and verify accreditation (for example, through state boards of pharmacy) when applicable. Assistance programs, insurance formularies, and discount cards may reduce cost for eligible patients.
If you encounter advertising or third-party sites suggesting no-prescription access, avoid purchasing and consult a healthcare professional. Your safety depends on correct diagnosis, dosing, and ongoing monitoring—cornerstones of responsible, legal access to Imdur in the U.S.
Imdur is the brand name for isosorbide mononitrate, a long-acting nitrate that relaxes blood vessels. It reduces the heart’s workload by dilating veins (lowering preload) and arteries, improving blood flow to the heart muscle and preventing angina.
Imdur is used to prevent chronic stable angina (chest pain) due to coronary artery disease. It is not intended to treat an acute angina attack; fast-acting nitroglycerin is used for sudden chest pain.
Take Imdur at the same time each day as prescribed, swallowing the tablet whole with water. Do not crush, chew, or split the extended-release tablet, as this can release the entire dose at once and increase side effects.
If you miss a dose, take it when you remember unless it’s close to the time of your next dose; in that case, skip the missed dose and resume your regular schedule. Do not double up to make up for a missed dose.
No. Extended-release Imdur tablets must be swallowed whole. Crushing, chewing, or splitting can cause dose dumping and raise the risk of low blood pressure, dizziness, and fainting.
Imdur extended-release usually begins working within 1–2 hours and helps prevent angina for about 12–24 hours, depending on the formulation and dose. It is not for immediate relief of chest pain.
Headache, flushing, dizziness, lightheadedness, and low blood pressure are common, especially when starting therapy or increasing the dose. Headaches often lessen after a few days as your body adjusts.
Vasodilation widens blood vessels, which can trigger headaches. They often improve with continued use; ask your clinician if you can use over-the-counter pain relievers like acetaminophen. Do not stop Imdur abruptly without medical advice.
Seek urgent care for severe dizziness or fainting, persistent chest pain unrelieved by fast-acting nitroglycerin, signs of an allergic reaction, or blue/gray discoloration of lips or fingers. Report sustained low blood pressure or a very slow heart rate to your clinician.
Alcohol can enhance the blood-pressure-lowering effect of Imdur and increase dizziness or fainting. If you drink, do so cautiously and avoid activities that require alertness until you know how you respond.
Do not use Imdur with phosphodiesterase-5 inhibitors such as sildenafil (Viagra), tadalafil (Cialis), vardenafil, or with riociguat; combining these can cause life-threatening hypotension. Tell your clinician about all drugs and supplements you take.
Imdur can lower blood pressure and may cause reflex fast heartbeat in some people. Rise slowly from sitting or lying positions, and use caution driving or operating machinery until you know your response.
With continuous nitrate exposure, the body can become less responsive (tolerance), reducing effectiveness. Imdur is typically dosed once daily to create a low-nitrate period each day, helping preserve its antianginal effect.
No. Imdur is for prevention, not immediate relief. For sudden chest pain, use short-acting nitroglycerin tablets or spray as your clinician prescribed and seek emergency care if pain persists.
Yes, Imdur is often combined with beta-blockers or calcium channel blockers for better angina control. Your clinician will tailor doses to balance symptom relief with blood pressure and heart rate.
Safety data are limited. Use during pregnancy or breastfeeding only if the potential benefit justifies the potential risk; consult your obstetrician or pediatrician for individualized guidance.
Do not stop abruptly, as this can trigger rebound angina. Your clinician may recommend a gradual taper and an alternative plan if discontinuation is needed.
Store at room temperature, away from moisture and heat, in the original container. Keep out of reach of children and do not use expired medication.
FDA-approved generics contain the same active ingredient and are considered therapeutically equivalent. Release profiles can vary slightly; if you notice changes in control or side effects after a switch, discuss with your clinician.
Yes, but older adults may be more sensitive to blood pressure drops and dizziness. Lower starting doses and careful monitoring are often used.
Imdur prevents angina over many hours; it is not for rapid relief. Sublingual nitroglycerin works within minutes to stop an active angina attack but has a short duration of action.
Both are long-acting nitrates for prevention. Imdur is an oral once-daily option, while transdermal nitroglycerin provides steady delivery via a patch that is worn for part of the day with a daily nitrate-free interval; choice depends on preference, skin tolerance, cost, and response.
Both are nitrates, but isosorbide dinitrate has a shorter half-life and is often given two to three times daily with a nitrate-free period. Imdur (isosorbide mononitrate) is active without liver conversion and commonly dosed once daily.
Both contain isosorbide mononitrate; ER provides smoother, longer coverage with once-daily dosing, while IR (e.g., Monoket) is typically taken twice daily with a schedule that preserves a nitrate-free interval. ER may reduce peak-related side effects for some patients.
Imdur provides baseline prevention. Sublingual nitroglycerin can be used just before exertion likely to trigger angina for short-term protection. Many patients use both under clinician guidance.
Nitroglycerin ointment offers flexible, short-to-intermediate duration prevention and is applied to the skin, while Imdur is a once-daily pill. Ointment can be useful when oral dosing isn’t feasible or when adjustable timing is desired.
Both can help, but tolerance can develop with continuous exposure. Patches are often worn during the day and removed at night or vice versa, depending on symptom pattern. Imdur timing can be adjusted to target peak coverage; your clinician will individualize the plan.
In heart failure with reduced ejection fraction, the evidence-based nitrate regimen is isosorbide dinitrate combined with hydralazine in select patients. Imdur is not a substitute for that combination; discuss the right agent for your condition.
All nitrates can cause tolerance if exposure is continuous. Imdur’s once-daily ER formulation makes it easier to build in a nitrate-free interval, which helps limit tolerance compared with multiple daily doses that lack a low-nitrate period.
Clinical effectiveness is expected to be the same. Some patients notice differences in side effects or symptom control when switching manufacturers due to excipients and release characteristics; if that occurs, ask about staying with a consistent product.
Switching requires careful timing to maintain a nitrate-free interval and avoid overlap that can increase tolerance or hypotension. Your clinician will provide a specific conversion and schedule based on doses and symptom patterns.
No. All nitrates share key interactions, especially absolute contraindications with PDE-5 inhibitors (sildenafil, tadalafil, vardenafil) and riociguat due to severe hypotension risk.
Imdur ER and transdermal nitroglycerin can both provide many hours of coverage, but both require a daily nitrate-free period to minimize tolerance. The best option depends on lifestyle, adherence, side effects, and cost.
Generic isosorbide mononitrate ER is typically inexpensive and convenient once daily. Some patches or brand-name products may cost more; insurance coverage and local pricing often determine the most economical choice.